Tony Petrella

Professeur adjoint de clinique

Faculté de médecine - Département de pathologie et biologie cellulaire

tony.petrella@umontreal.ca

Autres numéros : 514 252-3498 #4109 (Travail 1) 514 343-5755 (Télécopieur)

Autre courriel : tpetrella.hmr@ssss.gouv.qc.ca (Travail)

Portrait

Prix et distinctions

Membre suppléant de l’Executive Committee of the International Society of DermatoPathology

Affiliations et responsabilités

Enseignement et encadrement

Projets

Rayonnement

Autres activités et contributions

Expert de l’INCA (Institut National du Cancer) pour la pathologie lymphomateuse pour la
région Est de la France
Membre du Conseil Scientifique du Groupe Français d’Étude des Lymphomes Cutanés ; Appui à plusieurs chercheurs
Membre du Comité de Relecture Anatomo-Pathologique du LYSA (Lymphoma Study
Association ; ancien G.E.L.A.)
Participation à la rédaction de chapitre de livres :
- Classification of Tumours of Haematopoietic and Lymphoid Tissue. World Health Organization 2016; 5th Edition :
  - Blastic plasmacytoid dendritic cell neoplasms.
  - Acral primary cutaneous CD8 positive T-cell lymphomas.

Publications et communications

Publications

Laban É, Beylot-Barry M, Ortonne N, Battistella M, Carlotti A, de Muret A, Wechsler J, Balme B, Petrella T, Lamant L, Frouin É, Merlio JP, Vergier B. Cutaneous lymphoproliferations: Proposal for the use of diagnostic algorithms based on 2760 cases of cutaneous lymphoproliferations taken from the INCa networks (LYMPHOPATH and GFELC) over a two-year period. Ann Pathol. 2015 Apr;35(2):131-47.
Nadal M, Kervarrec T, Machet MC, Petrella T, Machet L. Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide. Acta Derm Venereol. 2015 Jul;95(6):758-9.
Osio A, Battistella M, Feugeas JP, Cuccuini W, Noguera ME, Petrella T, Raffoux E, Janin A, Vignon-Pennamen MD. Myelodysplasia cutis versus Leukaemia Cutis. J Invest Dermatol. 2015 Sep;135(9):2321-4

Laban É, Beylot-Barry M, Ortonne N, Battistella M, Carlotti A, de Muret A, Wechsler J, Balme B, Petrella T, Lamant L, Frouin É, Merlio JP, Vergier B. Cutaneous lymphoproliferations: proposal for the use of diagnostic algorithms based on 2760 cases of cutaneous lymphoproliferations taken from the INCa networks (LYMPHOPATH and GFELC) over a two-year period. Ann Pathol. 2015 Apr;35(2):131-47.
De Leval L, Parrens M, Le Bras F, Jais JP, Fataccioli V, Martin A, Lamant L, Delarue R, Berger F, Arbion F, Bossard C, Copin MC, Canioni D, Charlotte F, Damaj G, Dartigues P, Fabiani B, Ledoux-Pilon A, Montagne K, Molina T, Patey M, Tas P, Peoch M, Petit B, Petrella T, Picquenot JM, Rousset T, Rousselet MC, Soubeyran I, Thiebault S, Tournilhac O, Xerri L, Gisselbrecht C, Haioun C, Delsol G, Gaulard P. Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets. Haematologica. 2015 Sep;100(9):e361-4.
Copie-Bergman C, Cuillière-Dartigues P, Baia M, Briere J, Delarue R, Canioni D, Salles G, Parrens M, Belhadj K, Fabiani B, Recher C, Petrella T, Ketterer N, Peyrade F, Haioun C, Nagel I, Siebert R, Jardin F, Leroy K, Jais JP, Tilly H, Molina TJ, Gaulard P. MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study. Blood. 2015 Nov 26;126(22):2466-74
Kluk J, Kai A, Koch D, Taibjee SM, O'Connor S, Persic M, Morris S, Whittaker S, Cerroni L, Kempf W, Petrella T, Robson A. Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient. J Cutan Pathol. 2016 Feb;43(2):125-36
Laurent C, Delas A, Gaulard P, Haioun C, Moreau A, Xerri L, Traverse-Glehen A, Rousset T, Quintin-Roue I, Petrella T, Emile JF, Amara N, Rochaix P, Chenard-Neu MP, Tasei AM, Menet E, Chomarat H, Costes V, Andrac-Meyer L, Michiels JF, Chassagne-Clement C, de Leval L, Brousset P, Delsol G, Lamant L. Breast Implant Associated Anaplastic Large cell Lymphoma: two distinct clinicopathological variants with different outcomes. Ann Oncol. 2016 Feb;27(2):306-14.
Dubois S, Viailly PJ, Mareschal S, Bohers E, Bertrand P, Ruminy P, Maingonnat C, Jais JP, Peyrouze P, Figeac M, Molina TJ, Desmots F, Fest T, Haioun C, Lamy T, Copie-Bergman C, Briere J, Petrella T, Canioni D, Fabiani B, Coiffier B, Delarue R, Peyrade F, Bosly A, Andre M, Ketterer N, Salles G, Tilly H, Leroy K, Jardin F. Next Generation Sequencing in Diffuse Large B Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study. Clin Cancer Res. 2016 Jun 15;22(12):2919-28.
Michonneau D, Petrella T, Ortonne N, Ingen-Housz-Oro S, Franck N, Barete S, Battistella M, BEYLOT-BARRY M, Vergier B, Maynadié M, Bodemer C, Hermine O, Bagot M, Brouss N and Fraitag S. Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than Polychemotherapy. Acta Derm Venereol. 2016 Oct 10. [Epub ahead of print]
Berdugo J, Dumont-Mackay V, Brissy-Lachery S, Leclerc YE, Doyon J, Mitchell A, Petrella T, Desy D. Cutaneous Apocrine Carcinoma with an In Situ Component and Histiocytoid and Signet-ring Cells. American Journal of Dermatopathology, in press